These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 2876749)

  • 1. CPP, a new potent and selective NMDA antagonist. Depression of central neuron responses, affinity for [3H]D-AP5 binding sites on brain membranes and anticonvulsant activity.
    Davies J; Evans RH; Herrling PL; Jones AW; Olverman HJ; Pook P; Watkins JC
    Brain Res; 1986 Sep; 382(1):169-73. PubMed ID: 2876749
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison between the in vivo and in vitro activity of five potent and competitive NMDA antagonists.
    Lodge D; Davies SN; Jones MG; Millar J; Manallack DT; Ornstein PL; Verberne AJ; Young N; Beart PM
    Br J Pharmacol; 1988 Nov; 95(3):957-65. PubMed ID: 2905186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel anticonvulsant MK-801 binds to the activated state of the N-methyl-D-aspartate receptor in rat brain.
    Foster AC; Wong EH
    Br J Pharmacol; 1987 Jun; 91(2):403-9. PubMed ID: 2886170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacological selectivity of three NMDA antagonists.
    Childs AM; Evans RH; Watkins JC
    Eur J Pharmacol; 1988 Jan; 145(1):81-6. PubMed ID: 2894999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concentration-jump experiments with NMDA antagonists in mouse cultured hippocampal neurons.
    Benveniste M; Mienville JM; Sernagor E; Mayer ML
    J Neurophysiol; 1990 Jun; 63(6):1373-84. PubMed ID: 1972740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The NMDA antagonists, CPP and CGS 19755, lack affinity for central benzodiazepine receptors.
    Williams M; Loo PS; Sills MA
    Eur J Pharmacol; 1988 Oct; 155(1-2):185-7. PubMed ID: 2854072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ifenprodil and SL 82.0715 as cerebral anti-ischemic agents. II. Evidence for N-methyl-D-aspartate receptor antagonist properties.
    Carter C; Benavides J; Legendre P; Vincent JD; Noel F; Thuret F; Lloyd KG; Arbilla S; Zivkovic B; MacKenzie ET
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1222-32. PubMed ID: 2849669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of L-[3H]glutamate, D-[3H]aspartate, DL-[3H]AP5 and [3H]NMDA as ligands for NMDA receptors in crude postsynaptic densities from rat brain.
    Foster AC; Fagg GE
    Eur J Pharmacol; 1987 Jan; 133(3):291-300. PubMed ID: 2881792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CPP, a selective N-methyl-D-aspartate (NMDA)-type receptor antagonist: characterization in vitro and in vivo.
    Lehmann J; Schneider J; McPherson S; Murphy DE; Bernard P; Tsai C; Bennett DA; Pastor G; Steel DJ; Boehm C
    J Pharmacol Exp Ther; 1987 Mar; 240(3):737-46. PubMed ID: 2882014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscle relaxant and anticonvulsant activity of 3-((+/-)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid, a novel N-methyl-D-aspartate antagonist, in rodents.
    Turski L; Klockgether T; Sontag KH; Herrling PL; Watkins JC
    Neurosci Lett; 1987 Jan; 73(2):143-8. PubMed ID: 3029636
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Action of 3-((+/-)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP): a new and highly potent antagonist of N-methyl-D-aspartate receptors in the hippocampus.
    Harris EW; Ganong AH; Monaghan DT; Watkins JC; Cotman CW
    Brain Res; 1986 Sep; 382(1):174-7. PubMed ID: 2876750
    [TBL] [Abstract][Full Text] [Related]  

  • 12. L-glutamate has higher affinity than other amino acids for [3H]-D-AP5 binding sites in rat brain membranes.
    Olverman HJ; Jones AW; Watkins JC
    Nature; 1984 Feb 2-8; 307(5950):460-2. PubMed ID: 6141527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of CPP, a selective NMDA antagonist, in various rodent models of epilepsy. Comparison with other NMDA antagonists, and with diazepam and phenobarbital.
    Löscher W; Nolting B; Hönack D
    Eur J Pharmacol; 1988 Jul; 152(1-2):9-17. PubMed ID: 3061831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the binding of [3H]-CGS 19755: a novel N-methyl-D-aspartate antagonist with nanomolar affinity in rat brain.
    Murphy DE; Hutchison AJ; Hurt SD; Williams M; Sills MA
    Br J Pharmacol; 1988 Nov; 95(3):932-8. PubMed ID: 2850065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of competitive NMDA receptor antagonists on excitatory amino acid-evoked currents in mouse spinal cord neurones.
    D'Hooge R; Raes A; Van de Vijver G; Van Bogaert PP; De Deyn PP
    Fundam Clin Pharmacol; 1999; 13(1):67-74. PubMed ID: 10027090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity.
    Fagg GE; Olpe HR; Pozza MF; Baud J; Steinmann M; Schmutz M; Portet C; Baumann P; Thedinga K; Bittiger H
    Br J Pharmacol; 1990 Apr; 99(4):791-7. PubMed ID: 1972895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioligand labeling of N-methyl-D-aspartic acid (NMDA) receptors by [3H](+-)-3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid in brain synaptic membranes treated with Triton X-100.
    Yoneda Y; Ogita K; Kouda T; Ogawa Y
    Biochem Pharmacol; 1990 Jan; 39(1):225-8. PubMed ID: 2153381
    [No Abstract]   [Full Text] [Related]  

  • 18. Epileptiform bursts elicited in CA3 hippocampal neurons by a variety of convulsants are not blocked by N-methyl-D-aspartate antagonists.
    Neuman R; Cherubini E; Ben-Ari Y
    Brain Res; 1988 Sep; 459(2):265-74. PubMed ID: 2902900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regionally different N-methyl-D-aspartate receptors distinguished by ligand binding and quantitative autoradiography of [3H]-CGP 39653 in rat brain.
    Mugnaini M; van Amsterdam FT; Ratti E; Trist DG; Bowery NG
    Br J Pharmacol; 1996 Nov; 119(5):819-28. PubMed ID: 8922727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding of [3H]3-(2-carboxypiperazin-4-yl)propyl-1-phosphonic acid to rat brain membranes: a selective, high-affinity ligand for N-methyl-D-aspartate receptors.
    Murphy DE; Schneider J; Boehm C; Lehmann J; Williams M
    J Pharmacol Exp Ther; 1987 Mar; 240(3):778-84. PubMed ID: 3031274
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.